Loracarbef
- 1 May 1993
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 45 (5), 716-736
- https://doi.org/10.2165/00003495-199345050-00008
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Loracarbef vs. cefaclor in pediatric skin and skin structure infectionsThe Pediatric Infectious Disease Journal, 1992
- Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritisThe American Journal of Medicine, 1992
- Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.1992
- Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.1992
- Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.1991
- In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.The Journal of Antibiotics, 1989
- Pharmacokinetics of LY163892 in infants and childrenAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of LY163892 against pathogens isolated from pediatric patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- In vitro susceptibilities of common pediatric pathogens to LY163892Antimicrobial Agents and Chemotherapy, 1988
- In vitro activity and beta-lactamase stability of a new monobactam, B0-1165Antimicrobial Agents and Chemotherapy, 1987